THE KARYOTYPE OF PHILADELPHIA CHROMOSOME-NEGATIVE, BCR REARRANGEMENT-POSITIVE CHRONIC MYELOID-LEUKEMIA

被引：16
作者：
WEINSTEIN, ME
GROSSMAN, A
PERLE, MA
WILMOT, PL
VERMA, RS
SILVER, RT
ARLIN, Z
ALLEN, SL
AMOROSI, E
WAINTRAUB, SE
SHAPIRO, LR
BENN, PA
机构：
[1] WESTCHESTER CTY MED CTR,VALHALLA,NY 10595
[2] NEW YORK MED COLL,VALHALLA,NY 10595
[3] NYU MED CTR,NEW YORK,NY 10016
[4] SUNY HLTH SCI CTR,LONG ISLAND COLL HOSP,BROOKLYN,NY
[5] CORNELL UNIV,MED CTR,NEW YORK HOSP,NEW YORK,NY 10021
[6] HOLY NAME HOSP,TEANECK,NJ
[7] CORNELL UNIV,N SHORE UNIV HOSP,COLL MED,MANHASSET,NY 11030
来源：
CANCER GENETICS AND CYTOGENETICS | 1988年 / 35卷 / 02期
关键词：
D O I：
10.1016/0165-4608(88)90244-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：223 / 229
页数：7
相关论文
共 50 条
[31]   PHILADELPHIA CHROMOSOME-NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA AND CHRONIC MYELOMONOCYTIC LEUKEMIA [J].
KANTARJIAN, HM ;
KURZROCK, R ;
TALPAZ, M .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1990, 4 (02) :389-404
[32]   Translocation of BCR to chromosome 9 in a Philadelphia-negative chronic myeloid leukemia [J].
Brunel, V ;
Sainty, D ;
Costello, R ;
Mozziconacci, MJ ;
Simonetti, A ;
Arnoulet, C ;
Coignet, L ;
Bouabdallah, R ;
Gastaut, JA ;
Gabert, J ;
LafagePochitaloff, M .
CANCER GENETICS AND CYTOGENETICS, 1995, 85 (01) :82-84
[33]   Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridization [J].
Seong, D ;
Kantarjian, HM ;
Albitar, M ;
Arlinghaus, R ;
Xu, J ;
Talpaz, M ;
Rios, MB ;
Guo, JQ ;
O'Brien, S ;
Siciliano, M .
ANNALS OF ONCOLOGY, 1999, 10 (08) :955-959
[34]   LACK OF BCR REARRANGEMENT IN JUVENILE CHRONIC MYELOID-LEUKEMIA [J].
TOREN, A ;
MANDEL, M ;
AMARIGLIO, N ;
HAKIM, Y ;
BROKSIMONI, F ;
RECHAVI, G ;
NEUMANN, Y ;
RAMOT, B .
MEDICAL AND PEDIATRIC ONCOLOGY, 1991, 19 (06) :493-495
[35]   Progression of Philadelphia positive chronic myeloid leukemia to Philadelphia negative and bcr-abl positive disease [J].
Zivanovic, Biljana Todoric ;
Strnad, Milica ;
Stamatovic, Dragana ;
Elez, Marija .
CHROMOSOME RESEARCH, 2013, 21 :S105-S106
[36]   QUANTIFICATION OF THE BREAKPOINT CLUSTER REGION REARRANGEMENT FOR CLINICAL MONITORING IN PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA [J].
VERSCHRAEGEN, CF ;
TALPAZ, M ;
HIRSCHGINSBERG, CF ;
PHERWANI, R ;
RIOS, MB ;
STASS, SA ;
KANTARJIAN, HM .
BLOOD, 1995, 85 (10) :2705-2710
[37]   PYODERMA GANGRAENOSUM ASSOCIATED WITH PHILADELPHIA-CHROMOSOME-NEGATIVE CHRONIC MYELOID-LEUKEMIA [J].
KOVARY, PM ;
LONAUER, G ;
NIEDORF, H ;
NAUTSCH, C ;
PAWLOWITZKI, IH .
DERMATOLOGICA, 1977, 154 (06) :360-366
[38]   Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase [J].
Jootar, S. .
BLOOD REVIEWS, 2007, 21 :S121-S121
[39]   M-BCR BREAKPOINT LOCATION DOES NOT PREDICT SURVIVAL IN PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA [J].
ZACCARIA, A ;
MARTINELLI, G ;
BUZZI, M ;
ZUFFA, E ;
ZAMAGNI, MD ;
TESTONI, N ;
RUSSO, D ;
GUERRASIO, A ;
SAGLIO, G ;
TURA, S .
HAEMATOLOGICA, 1992, 77 (01) :16-20
[40]   IMMUNOLOGICAL CHARACTERIZATION OF THE TUMOR-SPECIFIC BCR ABL JUNCTION OF PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA [J].
BARRETT, J ;
GUIMARAES, A ;
CULLIS, J ;
GOLDMAN, JM .
STEM CELLS, 1993, 11 :104-108
12345